{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:59:36Z","timestamp":1780433976873,"version":"3.54.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:00:00Z","timestamp":1496966400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00277-017-3039-1","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T22:44:19Z","timestamp":1496961859000},"page":"1577-1578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p)"],"prefix":"10.1007","volume":"96","author":[{"given":"Marcelo Pitombeira de","family":"Lacerda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayara Ribeiro","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Eiko","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre Domingues","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita Brito Medeiros da","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lourdes Lopes Ferrari de","family":"Chauffaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus Vescovi","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihoko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Arrais","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,9]]},"reference":[{"key":"3039_CR1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.seminoncol.2016.02.011","volume":"43","author":"KA Rogers","year":"2016","unstructured":"Rogers KA, Woyachn JA (2016) Secondary autoimmune cytopenias in chronic lymphocytic leukemia. Semin Oncol 43:300\u2013310","journal-title":"Semin Oncol"},{"issue":"1","key":"3039_CR2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11899-017-0366-1","volume":"12","author":"M Tsang","year":"2017","unstructured":"Tsang M, Parikh SA (2017) A concise review of autoimmune cytopenias in chronic lymphocytic leukemia. Curr Hematol Malig rep 12(1):29\u201338","journal-title":"Curr Hematol Malig rep"},{"issue":"2","key":"3039_CR3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1470-2045(17)30012-8","volume":"18","author":"JF Seymour","year":"2017","unstructured":"Seymour JF, Ma S, Brander DM et al (2017) Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study. Lancet Oncol 18(2):230\u2013240","journal-title":"Lancet Oncol"},{"key":"3039_CR4","doi-asserted-by":"crossref","unstructured":"Mato AR, Hill BT, Lamanna N et al. Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. Ann Oncol 2017 mdx031.","DOI":"10.1093\/annonc\/mdx031"},{"issue":"2","key":"3039_CR5","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1038\/bcj.2017.5","volume":"7","author":"M Montillo","year":"2017","unstructured":"Montillo M, O'Brien S, Tedeschi A et al (2017) Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study. Blood Cancer J 7(2):e524","journal-title":"Blood Cancer J"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3039-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3039-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3039-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T02:21:44Z","timestamp":1501554104000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3039-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,9]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3039"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3039-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,9]]}}}